CING
Price
$4.04
Change
-$0.02 (-0.49%)
Updated
Dec 24 closing price
Capitalization
27.3M
Intraday BUY SELL Signals
TRAW
Price
$1.24
Change
+$0.01 (+0.81%)
Updated
Dec 24 closing price
Capitalization
9.91M
Intraday BUY SELL Signals
Interact to see
Advertisement

CING vs TRAW

Header iconCING vs TRAW Comparison
Open Charts CING vs TRAWBanner chart's image
Cingulate
Price$4.04
Change-$0.02 (-0.49%)
Volume$56.51K
Capitalization27.3M
Traws Pharma
Price$1.24
Change+$0.01 (+0.81%)
Volume$40.76K
Capitalization9.91M
CING vs TRAW Comparison Chart in %
CING
Daily Signal:
Gain/Loss:
TRAW
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CING vs. TRAW commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a Buy and TRAW is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (CING: $4.04 vs. TRAW: $1.24)
Brand notoriety: CING and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 36% vs. TRAW: 9%
Market capitalization -- CING: $27.3M vs. TRAW: $9.91M
CING [@Biotechnology] is valued at $27.3M. TRAW’s [@Biotechnology] market capitalization is $9.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 0 FA rating(s) are green whileTRAW’s FA Score has 2 green FA rating(s).

  • CING’s FA Score: 0 green, 5 red.
  • TRAW’s FA Score: 2 green, 3 red.
According to our system of comparison, TRAW is a better buy in the long-term than CING.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 7 TA indicator(s) are bullish while TRAW’s TA Score has 4 bullish TA indicator(s).

  • CING’s TA Score: 7 bullish, 3 bearish.
  • TRAW’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CING is a better buy in the short-term than TRAW.

Price Growth

CING (@Biotechnology) experienced а +5.76% price change this week, while TRAW (@Biotechnology) price change was -11.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CING($27.3M) has a higher market cap than TRAW($9.91M). TRAW has higher P/E ratio than CING: TRAW (0.50) vs CING (0.02). CING YTD gains are higher at: -18.053 vs. TRAW (-86.036). TRAW has higher annual earnings (EBITDA): -15.77M vs. CING (-19.98M). TRAW (6.42M) and CING (6.12M) have equal amount of cash in the bank . TRAW has higher revenues than CING: TRAW (2.85M) vs CING (0).
CINGTRAWCING / TRAW
Capitalization27.3M9.91M276%
EBITDA-19.98M-15.77M127%
Gain YTD-18.053-86.03621%
P/E Ratio0.020.505%
Revenue02.85M-
Total Cash6.12M6.42M95%
Total Debt4.58MN/A-
FUNDAMENTALS RATINGS
TRAW: Fundamental Ratings
TRAW
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
17
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CINGTRAW
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CING
Daily Signal:
Gain/Loss:
TRAW
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAIN59.810.85
+1.44%
Main Street Capital Corp
KTTA1.170.01
+0.86%
Pasithea Therapeutics Corp
BK118.221.00
+0.85%
Bank of New York Mellon Corp
ONTF5.810.04
+0.69%
ON24
EVLV6.66-0.10
-1.48%
Evolv Technologies Holdings

CING and

Correlation & Price change

A.I.dvisor tells us that CING and RAPT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CING and RAPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-0.49%
RAPT - CING
31%
Poorly correlated
+1.24%
ABCL - CING
31%
Poorly correlated
+0.81%
RXRX - CING
30%
Poorly correlated
+0.92%
TRAW - CING
29%
Poorly correlated
+0.81%
BEIGF - CING
29%
Poorly correlated
N/A
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with RAPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
+0.81%
RAPT - TRAW
49%
Loosely correlated
+1.24%
SLGL - TRAW
42%
Loosely correlated
+0.83%
MDGL - TRAW
39%
Loosely correlated
+0.10%
CYTK - TRAW
36%
Loosely correlated
+1.41%
ORMP - TRAW
34%
Loosely correlated
+6.78%
More